Effect of Inhibiting NCL Expression on Drug-Resistance of Chronic Myeloid Leukemia Cell Line K562 and Its Resistant Cells / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1064-1070, 2019.
Article
em Zh
| WPRIM
| ID: wpr-771838
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE@#To construct a K562 and adriamycin-resistant K562 (KAR) cell line with stably down-regulation of NCL (nucleolin) expression, and to investigate the effect of NCL down-regulation on the drug resistance in K562 and KAR cells.@*METHODS@#K562 and KAR cells were infected with lentivirus, and stably transfected cell clones were obtained by puromycin screening. The cell proliferation was detected by MTS assay, the cell apoptosis was detected by flow cytometry, and the expression level of drug resistance related genes was detected by real-time PCR.@*RESULTS@#The K562 and KAR cells with stable down-regulation of NCL were successfully constructed. Compared with the control group, the proliferation of K562 and KAR cells with down-regulating NCL expression decreased significantly (P <0.05), the apoptosis of cells increased significantly (P <0.05), and cell resistance to adriamycin was down-regulated.@*CONCLUSION@#Inhibition of NCL expression may increase the sensitivity of cells to adriamycin, which may be related with the promotion of apoptosis of K562 and KAR cells.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fosfoproteínas
/
Leucemia Mielogênica Crônica BCR-ABL Positiva
/
Doxorrubicina
/
Proteínas de Ligação a RNA
/
Apoptose
/
Resistencia a Medicamentos Antineoplásicos
/
Células K562
Limite:
Humans
Idioma:
Zh
Revista:
Journal of Experimental Hematology
Ano de publicação:
2019
Tipo de documento:
Article